Silence Therapeutics Plc
(NASDAQ) SLN
Silence Therapeutics Plc Financials at a Glance
Market Cap
$363.70M
Revenue (TTM)
$559.00K
Net Income (TTM)
$88.61M
EPS (TTM)
$-1.88
P/E Ratio
-4.09
Dividend
$0.00
Beta (Volatility)
0.64 (Low)
Dividend
$0.00
Beta (Volatility)
0.64 (Low)
Price
$7.72
Volume
25,307
Open
$7.80
Price
$7.72
Volume
25,307
Open
$7.80
Previous Close
$7.72
Daily Range
$7.62 - $7.85
52-Week Range
$3.08 - $8.40
Dividend
$0.00
Beta (Volatility)
0.64 (Low)
Price
$7.72
Volume
25,307
Open
$7.80
Previous Close
$7.72
Daily Range
$7.62 - $7.85
52-Week Range
$3.08 - $8.40
SLN News
SLN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Silence Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
88
CEO
Iain Gladstone Ross
Website
www.silence-therapeutics.comHeadquarters
London, W14 8TH, GB
SLN Financials
Key Financial Metrics (TTM)
Gross Margin
62%
Operating Margin
-163%
Net Income Margin
-159%
Return on Equity
0%
Return on Capital
-77%
Return on Assets
-67%
Earnings Yield
-24.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$363.70M
Shares Outstanding
47.23M
Volume
25.31K
Short Interest
0.00%
Avg. Volume
319.88K
Financials (TTM)
Gross Profit
$344.00K
Operating Income
$89.75M
EBITDA
$89.20M
Operating Cash Flow
$62.27M
Capital Expenditure
$55.00K
Free Cash Flow
$62.33M
Cash & ST Invst.
$85.11M
Total Debt
$160.00K
Silence Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$34.00K
-99.9%
Gross Profit
$22.00K
-99.9%
Gross Margin
64.71%
N/A
Market Cap
$363.70M
N/A
Market Cap/Employee
$3.14M
N/A
Employees
116
N/A
Net Income
$11.77M
-183.0%
EBITDA
$12.35M
-271.7%
Quarterly Fundamentals
Net Cash
$85.27M
-42.1%
Accounts Receivable
$18.27M
-32.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-67.42%
N/A
Return on Invested Capital
-77.30%
N/A
Free Cash Flow
$17.34M
+30.4%
Operating Cash Flow
$17.29M
+30.5%